The aim of this study is to evaluate the efficacy and safety of Chantix as a means of reducing smoking rates in patients following Acute Coronary Syndrome. All study related testing will be completed at no cost to the patient. Compensation may occur for qualified patients. 


This Study Is Closed To Enrollment.


©2018 Heart Consultants P.C. All Rights Reserved